Business - November 6, 2023
AI use is increasing in medicine & life sciences
The speed at which artificial intelligence (AI) is becoming part of everyday life has taken much of the world by surprise, but perhaps less so in the Nordic countries where much of the infrastructure already exists to accommodate the new technology.
Business - November 2, 2023
Multiple issues need further investigation in SynAct trial
SynAct Pharma has announced evaluation of the 4-week RESOLVE Phase 2a clinical trial in moderate to severely active rheumatoid arthritis patients with an incomplete response to methotrexate. During the evaluation of the unblinded study data SynAct Pharma identified multiple issues that need further investigation before any conclusion on the outcome of the study can be […]
Business - November 1, 2023
Interview: Jonina Gudmundsdottir, Coripharma
In the heart of Iceland’s life sciences industry, Jonina Gudmundsdottir, the CEO of Coripharma, is making her mark. With a deep understanding of the industry’s challenges and a relentless drive for excellence, Gudmundsdottir has steered Coripharma toward transformative success. Iceland’s life sciences industry has thrived in recent years, propelled by its unique strengths. With a […]
Business - October 31, 2023
Aqilion reports positive Phase I results
The company has reported results from its ARIA-1 study in healthy volunteers with the drug candidate AQ280, a selective proprietary JAK1 inhibitor, being developed as a treatment for eosinophilic esophagitis (EoE) within the Regulus program. Healthy subjects were administered single or multiple doses in a sequential escalating dosing schedule until the maximum planned dose of […]
Business - October 30, 2023
BioArctic’s lecanemab – one of the world’s best inventions
TIME has selected lecanemab as one of the best inventions of 2023 in the Medical Care category. Lecanemab is based on BioArctic’s founder Professor Lars Lannfelt’s research. It is the first and only fully approved treatment in the US and Japan for patients with mild cognitive impairment or mild Alzheimer’s disease that targets the underlying […]
Business - October 25, 2023
Q&A: The Baltics – An emerging life science hub
NLS asked Dominykas Milašius, Venture Partner at Baltic Sandbox Ventures and co-founder of Delta biosciences, about the Baltic business climate for life science startups and companies, and opportunities for investments and collaborations in Estonia, Latvia and Lithuania. Describe Baltic Sandbox Ventures’ investments in life science companies/startups? What kind of companies are you focusing your investments […]
